This site is intended for healthcare professionals only
LoginRegister
HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuitHIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit
Zydus Lifesciences ropes in Tushar Shroff as President-FinanceZydus Lifesciences ropes in Tushar Shroff as President-Finance
JnJ Imaavy gets USFDA okay for generalized myasthenia gravisJnJ Imaavy gets USFDA okay for generalized myasthenia gravis
Novartis to acquire kidney disease drug maker Regulus Therapeutics for up to 1.7 billionNovartis to acquire kidney disease drug maker Regulus Therapeutics for up to 1.7 billion
Strides Pharma Science Singapore arm secures USFDA nod for nonsteroidal anti-inflammatory drugStrides Pharma Science Singapore arm secures USFDA nod for nonsteroidal anti-inflammatory drug
Govt Issues Export Guidelines for Doxycycline 100 mg Dispersible TabletsGovt Issues Export Guidelines for Doxycycline 100 mg Dispersible Tablets
Lupin Digital Health introduces Post-Procedure Home-Based Care GuideRevise study protocol: CDSCO Panels tells Lupin on Ranibizumab Solution for Injection 10 mg/mL
Gland Pharma bags USFDA nod for glaucoma drugGland Pharma bags USFDA nod for glaucoma drug
USFDA approves AbbVie giant cell arteritis drug Rinvoq in adultsUSFDA approves AbbVie giant cell arteritis drug Rinvoq in adults
TPG to acquire 35% stake in SCHOTT Poonawalla from SIIStrides Pharma buys four approved ANDAs from Nostrum Labs for over Rs 17 crore
Alembic Pharma gets USFDA EIR for Panelav facilityUSFDA issues EIR for Alembic Pharma Panelav facility
AstraZeneca Breztri met primary endpoints in Phase III trials in asthmaFixed duration Calquence based regimens recommended for EMA Committee for chronic lymphocytic...
X